Enjoy complimentary customisation on priority with our Enterprise License!
The extracorporeal membrane oxygenation machines market size is forecast to increase by USD 243.6 million between 2022 and 2027, accelerating at a CAGR of 10.05%. In 2017, the US held the largest market share, projecting an annual revenue of USD 39.63 million. The report offers extensive research analysis on the Extracorporeal Membrane Oxygenation Machines Market, with a categorization based on modality, including veno-venous, arterio-venous, and veno-arterial. It further segments the market by Product, encompassing ECMO machines and Softwares. Additionally, the report provides geographical segmentation, covering North America, Europe, Asia, and Rest of World (ROW). Market size, historical data (2017-2021), and future projections are presented in terms of value (in USD million) for all the mentioned segments.
To learn more about this report, Download Report Sample
The increasing incidence of respiratory and heart failure is notably driving the market growth. The increasing prevalence of various chronic cardiovascular diseases (CVD) and respiratory diseases leads to a rise in the number of deaths. Patients with chronic CVD and respiratory diseases have a high risk of developing respiratory or cardiac failure. Extracorporeal membrane oxygenation machines are used as life-support devices or machines for the treatment of patients with chronic cardiovascular and respiratory diseases.
The prevalence of CVDs and other heart diseases has increased significantly across the world. Ischemic heart disease, coronary artery disease, and myocardial infarctions are some of the major heart diseases that affect the population. Extracorporeal membrane oxygenation machines minimize the chances of cardiac failure in people with chronic cardiovascular disease. This is expected to fuel the growth of the global extracorporeal membrane oxygenation machines market during the forecast period.
The veno-venous segment showed a gradual increase in the market share of USD 194.24 million in 2017 and continued to grow by 2021. The increasing prevalence of various chronic respiratory diseases, high incidence of respiratory failures, the growing cases of lung transplants, and increasing technological advances are the major factors contributing to the growth of the veno-venous and arterio-venous extracorporeal membrane oxygenation machines segment of the global extracorporeal membrane oxygenation machines market.
North America is estimated to contribute 37% to the growth of the global market during the forecast period. The growth of the market in the region is mainly driven by the increasing prevalence of cardiovascular and respiratory diseases, the increasing number of lung and heart transplant procedures, the rising adoption of technologically advanced medical devices, increasing awareness among healthcare professionals about the benefits of the extracorporeal membrane oxygenation process, and increasing healthcare expenditure. In addition, the growing presence of vendors that manufacture extracorporeal membrane oxygenation machines and increasing technological advances in extracorporeal membrane oxygenation procedures are driving the growth of the market in North America.
To understand geographic trends Download Report Sample
The Extracorporeal Membrane Oxygenation Machines Market is fragmented in nature. Some significant players include Abbott Laboratories, Abiomed Inc., Braile Biomedica, Chalice Medical Ltd and CytoSorbents Europe GmbH.
The research report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
Eurosets Srl, Fresenius Medical Care AG and Co. KGaA, Getinge AB, LivaNova Plc, MC3 Cardiopulmonary, Medtronic Plc, MicroPort Scientific Corp., Nipro Corp., OriGen Biomedical Inc., Palex Medical SA, Sechrist Industries Inc., Senko Medical Industry Co. Ltd., Spectrum Medical Ltd., Terumo Corp., and Xenios AG
The extracorporeal membrane oxygenation machines market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 - 2027.
|
Extracorporeal Membrane Oxygenation Machines Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
167 |
|
Base year |
2022 |
|
Historic period |
2017 - 2021 |
|
Forecast period |
2023-2027 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 10.05% |
|
Market growth 2023-2027 |
USD 243.6 million |
|
Market structure |
Fragmented |
|
YoY growth 2022-2023(%) |
8.24 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 37% |
|
Key countries |
US, Canada, UK, Germany, and China |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Abbott Laboratories, Abiomed Inc., Braile Biomedica, Chalice Medical Ltd., CytoSorbents Europe GmbH, Eurosets Srl, Fresenius Medical Care AG and Co. KGaA, Getinge AB, LivaNova Plc, MC3 Cardiopulmonary, Medtronic Plc, MicroPort Scientific Corp., Nipro Corp., OriGen Biomedical Inc., Palex Medical SA, Sechrist Industries Inc., Senko Medical Industry Co. Ltd., Spectrum Medical Ltd., Terumo Corp., and Xenios AG |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Modality
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Certified ISO 9001 : 2015
We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.
We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.
Get lifetime access to our
Technavio Insights
Customized Report as per your Business Needs
Let us help you make report more suited to your requirements.
Get the report (PDF) sent to your email within minutes.
